"Introduction: BCG vaccine has shown consistently high efficacy against childhood tubercular meningitis and miliary tuberculosis and other mycobacterial diseases. It is considered to be a safe vaccine with a low incidence of adverse effects. Efficacy of BCG vaccine found in different clinical trials is variable in different geography.
Objectives: Study was done to assess the efficacy of BCG vac-cine.
Materials and Methods: All the children who were less than three years of age and were previously BCG vaccinated and not-vaccinated, were included in this study. A total of sixty (60) vaccinated children and sixty non-vaccinated children were selected. These children were followed up prospectively for 24 months, at the end of which, it was seen whether they developed tuberculosis or not.
Results: Out of these 60 children in both the cases and control groups, total number of BCG vaccinated children who developed TB were 4 (i.e. 6.6%) and total number of Non-BCG vaccinated children who developed TB were 12 (i.e. 20%). Thus, the efficacy of BCG vaccine calculated in our study was 67%.
Conclusion: Most studies in different parts of the world have shown that the efficacy of BCG vaccine varies from zero to eigh-ty percent. This study favors the efficacy of BCG vaccine. This vaccination strategy will be favorable for our children. Creation of awareness among the parents and family members for an early administration of BCG vaccine after child birth can be recom-mended."
BCG vaccine, efficacy, tuberculosis
Safety and efficacy of dietary supplement (gintonin-enriched fraction from ginseng) in subjective memory impairment: A randomized placebo-controlled trial.
Lee WJ, Shin YW, Chang H, Shin HR, Kim WW, Jung SW, Kim M, Nah SY
Integrative medicine research. 2022; 11(1): 100773
The behavioral immune system and vaccination intentions during the coronavirus pandemic.
Karlsson LC, Soveri A, Lewandowsky S, Karlsson L, Karlsson H, Nolvi S, Karukivi M, Lindfelt M, Antfolk J
Personality and individual differences. 2022; 185(): 111295
Determination of Bioenergetic Parameters in Mycobacterium ulcerans.
Thomas SS, Pethe K
Methods in molecular biology (Clifton, N.J.). 2022; 2387(): 219-230
Turbidity-Based MIC Assay and Characterization of Spontaneous Drug Resistant Mutants in Mycobacterium ulcerans.
Thomas SS, Kalia NP, Pethe K
Methods in molecular biology (Clifton, N.J.). 2022; 2387(): 209-217
Drug Efficacy Testing in the Mouse Footpad Model of Buruli Ulcer.
Converse PJ, Almeida DV, Nuermberger EL
Methods in molecular biology (Clifton, N.J.). 2022; 2387(): 195-207